Newer, bigger and better offices often come to startups that lock down a multi-million-dollar venture capital raises. Add Delphinus Medical Technologies to that list now that it has moved on up to a newer, bigger and better headquarters in Novi.
The biotech startup has called Plymouth its home for most of its five years. Then it landed one of the largest rounds of venture capital in Michigan history last fall. The $40 million Series C round (led by Farmington Hills-based Beringea
) will go toward developing and selling its whole breast ultrasound system, growing its team and finding a bigger place to house that team. At 21,000 square feet, the company's new home in Novi is three times larger than its previous office in Plymouth.
"It's just a fabulous facility," says Mark Forchette, president and CEO of Delphinus Medical Technologies
. "It has a great, inspiring cultural vibe to it."
Delphinus Medical Technologies is creating a new way to detect breast cancer utilizing technology spun out of Wayne State University and the Karmanos Cancer Institute
. SoftVue is a whole breast ultrasound system that allows physicians to image the entire breast, including the chest wall. The technology platform incorporates a circular ultrasound transducer, producing cross-sectional ultrasound cross-sections through the entire volume of breast tissue.
The new headquarters will provide more space for research and development of SoftVue
. Delphinus Medical Technologies has hired eight people so far this year, growing its team to just shy of 50 people.
Delphinus Medical Technologies signed a lease on its new office with the idea of providing enough room for R&D and also to act as a showcase for that technology. Forchette expects to host frequent visits from healthcare leaders, customers and vendors, so the company has added a dedicated demonstration room.
"We have room to grow," Forchette says. "We have a facility here that is multifunctional. We have lab space and office space and demonstration space."